Kristy Lair believes any challenge she faces in life can be turned into something positive to help someone else. Having ...

The FDA approved retifanlimab (Zynyz; Incyte) as the first and only first-line treatment for advanced anal cancer, supported ...

MILLIONS of women could be unknowingly increasing their risk of breast cancer by using everyday cosmetics and toiletries, a charity has warned. Shampoos, face creams and make-up may be harmless on ...

Beyond five days’ of statutory sick pay a year, your employer is not obliged to keep paying you if you fall ill ...

Welcome to the Relmada Therapeutics first-quarter 2025 earnings call. (Operator Instructions) As a reminder, this conference is being recorded, and will be available for replay on the location website ...

Q1 2025 Earnings Call Transcript May 12, 2025 Relmada Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0 ...

NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing ...

High-risk NMIBC is characterised by poor prognosis, with half of patients recurring despite effective treatment with the ...

Colin P.N. Dinney, MD, provides some background on translational analyses from the BOND-003 and CORE-001 trials.

You’ve probably heard of stages 1, 2, 3 and 4 – but there’s another diagnosis of cancer that you might not have heard of.

Women diagnosed with DCIS face a threefold higher risk of breast cancer mortality. Learn the warning signs, treatment options ...

At the American Urological Association (AUA) 2025 Annual Meeting in April, the Company announced positive updated interim ...